Wang Laboratory (IMAGE)
Caption
Scientists at The Jackson Laboratory are studying new therapeutic targets for acute myeloid leukemia (AML), an aggressive hematological malignancy that accounts for 80% of acute leukemia cases in adults.
Credit
The Jackson Laboratory
Usage Restrictions
none
License
Original content